Related Experiment Video
Updated: Jan 15, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Maintenance and Reliever Therapy in Pediatric Asthma: A Concise Review of Recent Evidence-Part I
Rahaf Alharbi1, Adel S Alharbi2
1Pharmaceutical Services Department, and Department of Pediatrics, Pediatric Sleep Disorders Center, Prince Sultan Military Medical City.
Insights
Inhaled corticosteroid-long-acting beta 2-agonist (ICS-LABA) therapies are effective for pediatric asthma. Maintenance and Reliever Therapy (MART) offers a potential alternative to improve adherence and outcomes.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Clinical Pharmacy
Background:
- Pediatric asthma is a growing global health concern, impacting children's quality of life.
- Current treatments include inhaled corticosteroids (ICS) and long-acting beta 2-agonists (LABAs).
- ICS-LABA combinations show efficacy but face challenges in adherence and optimal dosing.
Purpose of the Study:
- To review current evidence on ICS-LABA therapy for pediatric asthma.
- To introduce the Maintenance and Reliever Therapy (MART) approach.
- To evaluate MART as a potential alternative for improved pediatric asthma management.
Main Methods:
- Literature review of clinical trials and observational studies.
- Analysis of treatment efficacy, safety, and adherence data.
- Comparative assessment of ICS-LABA and MART strategies.
Main Results:
- ICS-LABA combinations effectively reduce asthma exacerbations and improve lung function.
- Concerns regarding adherence and inflammation masking persist with traditional ICS-LABA use.
- MART demonstrates potential for enhanced adherence and optimized symptom control.
Conclusions:
- ICS-LABA therapy remains a cornerstone for pediatric asthma management.
- MART presents a promising alternative, potentially improving treatment adherence and outcomes.
- Further research is needed to fully establish MART's long-term benefits in pediatric populations.
Abstract:
Pediatric asthma is a chronic inflammatory respiratory condition characterized by recurrent wheezing, chest tightness, breathlessness, and coughing, which can significantly impact quality of life and lead to hospitalization or long-term lung impairment. The prevalence of asthma has increased globally, with higher rates in urban areas and developing countries. Current management strategies emphasize inhaled corticosteroids (ICS) as the cornerstone of treatment, with long-acting beta 2-agonists (LABAs) introduced for patients requiring additional symptom control. ICS-LABA combinations have demonstrated efficacy in reducing exacerbations, improving lung function, and lowering health care utilization. However, concerns persist regarding adherence, potential masking of airway inflammation, and optimal dosing. The emerging maintenance and reliever therapy (MART) approach integrates ICS and formoterol into a single inhaler for both maintenance and symptom relief, aiming to enhance adherence and optimize treatment outcomes. This review examines the current evidence supporting ICS-LABA therapy and introduces MART as a potential alternative for pediatric asthma management.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Nursing Management
First, in...

